| Literature DB >> 24224681 |
Jignesh P Patel1, Roopen Arya.
Abstract
For patients prescribed chronic vitamin K antagonist therapy requiring a surgical or invasive procedure, the question of whether or not to bridge and how to bridge is commonly encountered in clinical practice. Bridging anticoagulation has evolved over the years and the evidence base for current practice is deficient in many areas. Clinical trials currently being completed with conventional anticoagulants should help strengthen the evidence base for future practice. The availability of novel oral anticoagulants is a welcome addition, though their optimal management peri-procedure is yet to be determined. Prospective multi-centre controlled studies that can provide the evidence base for novel oral anticoagulant peri-procedural management are required.Entities:
Keywords: anticoagulation; bridging; low molecular weight heparin; surgical procedures; vitamin K antagonist therapy
Mesh:
Substances:
Year: 2013 PMID: 24224681 DOI: 10.1111/bjh.12644
Source DB: PubMed Journal: Br J Haematol ISSN: 0007-1048 Impact factor: 6.998